nodes	percent_of_prediction	percent_of_DWPC	metapath
Dofetilide—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.0511	0.0915	CcSEcCtD
Dofetilide—KCNJ12—Activation of G protein gated Potassium channels—KCNJ10—amyotrophic lateral sclerosis	0.05	0.133	CbGpPWpGaD
Dofetilide—KCNJ12—Inwardly rectifying K+ channels—KCNJ10—amyotrophic lateral sclerosis	0.0421	0.112	CbGpPWpGaD
Dofetilide—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.0396	0.0709	CcSEcCtD
Dofetilide—KCNJ12—Activation of GABAB receptors—KCNJ10—amyotrophic lateral sclerosis	0.0358	0.0955	CbGpPWpGaD
Dofetilide—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0336	0.0602	CcSEcCtD
Dofetilide—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.0322	0.0576	CcSEcCtD
Dofetilide—KCNJ12—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.0274	0.0732	CbGpPWpGaD
Dofetilide—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0248	0.0444	CcSEcCtD
Dofetilide—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0212	0.038	CcSEcCtD
Dofetilide—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.0193	0.0346	CcSEcCtD
Dofetilide—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.0184	0.0329	CcSEcCtD
Dofetilide—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.0177	0.0318	CcSEcCtD
Dofetilide—KCNJ12—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.0166	0.0444	CbGpPWpGaD
Dofetilide—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0291	CcSEcCtD
Dofetilide—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0291	CcSEcCtD
Dofetilide—KCNJ12—medulla oblongata—amyotrophic lateral sclerosis	0.0135	0.201	CbGeAlD
Dofetilide—Injury—Riluzole—amyotrophic lateral sclerosis	0.0128	0.023	CcSEcCtD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0126	0.0336	CbGpPWpGaD
Dofetilide—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0216	CcSEcCtD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0116	0.031	CbGpPWpGaD
Dofetilide—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0208	CcSEcCtD
Dofetilide—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0201	CcSEcCtD
Dofetilide—KCNK2—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.0106	0.0282	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.0103	0.0274	CbGpPWpGaD
Dofetilide—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0182	CcSEcCtD
Dofetilide—KCNJ12—nervous system—amyotrophic lateral sclerosis	0.0101	0.151	CbGeAlD
Dofetilide—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00993	0.0178	CcSEcCtD
Dofetilide—KCNJ12—central nervous system—amyotrophic lateral sclerosis	0.00975	0.146	CbGeAlD
Dofetilide—KCNJ12—cerebellum—amyotrophic lateral sclerosis	0.00953	0.142	CbGeAlD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00947	0.0253	CbGpPWpGaD
Dofetilide—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00896	0.016	CcSEcCtD
Dofetilide—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00891	0.016	CcSEcCtD
Dofetilide—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00883	0.0158	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00874	0.0233	CbGpPWpGaD
Dofetilide—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00871	0.0156	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00844	0.0225	CbGpPWpGaD
Dofetilide—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.0083	0.0149	CcSEcCtD
Dofetilide—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00803	0.0144	CcSEcCtD
Dofetilide—KCNJ12—brain—amyotrophic lateral sclerosis	0.00774	0.116	CbGeAlD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00772	0.0206	CbGpPWpGaD
Dofetilide—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00729	0.013	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00726	0.0194	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00718	0.0192	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00718	0.0192	CbGpPWpGaD
Dofetilide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00687	0.0123	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0067	0.0179	CbGpPWpGaD
Dofetilide—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00649	0.0116	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00647	0.0173	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0064	0.0171	CbGpPWpGaD
Dofetilide—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00637	0.0114	CcSEcCtD
Dofetilide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00627	0.0112	CcSEcCtD
Dofetilide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00624	0.0112	CcSEcCtD
Dofetilide—Cough—Riluzole—amyotrophic lateral sclerosis	0.0062	0.0111	CcSEcCtD
Dofetilide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00613	0.011	CcSEcCtD
Dofetilide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00604	0.0108	CcSEcCtD
Dofetilide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00604	0.0108	CcSEcCtD
Dofetilide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00602	0.0108	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00592	0.0158	CbGpPWpGaD
Dofetilide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00579	0.0104	CcSEcCtD
Dofetilide—Shock—Riluzole—amyotrophic lateral sclerosis	0.0057	0.0102	CcSEcCtD
Dofetilide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0056	0.01	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0055	0.0147	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0055	0.0147	CbGpPWpGaD
Dofetilide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00528	0.00946	CcSEcCtD
Dofetilide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00524	0.00939	CcSEcCtD
Dofetilide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0052	0.00932	CcSEcCtD
Dofetilide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00517	0.00925	CcSEcCtD
Dofetilide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00496	0.00887	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0049	0.0131	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00474	0.00849	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00461	0.0123	CbGpPWpGaD
Dofetilide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00458	0.0082	CcSEcCtD
Dofetilide—KCNH2—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.00447	0.0119	CbGpPWpGaD
Dofetilide—KCNK2—brain—amyotrophic lateral sclerosis	0.00442	0.066	CbGeAlD
Dofetilide—KCNK2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00425	0.0114	CbGpPWpGaD
Dofetilide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00745	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00411	0.011	CbGpPWpGaD
Dofetilide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00396	0.0071	CcSEcCtD
Dofetilide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00686	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00376	0.01	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00366	0.00976	CbGpPWpGaD
Dofetilide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00654	CcSEcCtD
Dofetilide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00654	CcSEcCtD
Dofetilide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00363	0.0065	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00349	0.00933	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00349	0.00933	CbGpPWpGaD
Dofetilide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00616	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00311	0.00831	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00236	0.00629	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00236	0.00629	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00236	0.00629	CbGpPWpGaD
Dofetilide—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.00215	0.0321	CbGeAlD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00212	0.00565	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00195	0.00521	CbGpPWpGaD
Dofetilide—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.00192	0.0286	CbGeAlD
Dofetilide—KCNH2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0018	0.00481	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00174	0.00464	CbGpPWpGaD
Dofetilide—KCNH2—nervous system—amyotrophic lateral sclerosis	0.00161	0.0241	CbGeAlD
Dofetilide—KCNH2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00159	0.00425	CbGpPWpGaD
Dofetilide—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.00155	0.0232	CbGeAlD
Dofetilide—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.00152	0.0227	CbGeAlD
Dofetilide—KCNH2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00148	0.00395	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00148	0.00395	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00132	0.00352	CbGpPWpGaD
Dofetilide—KCNH2—brain—amyotrophic lateral sclerosis	0.00123	0.0184	CbGeAlD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00122	0.00325	CbGpPWpGaD
Dofetilide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.001	0.0149	CbGeAlD
Dofetilide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000963	0.0144	CbGeAlD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000609	0.00162	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00055	0.00147	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000517	0.00138	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000246	0.000656	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000243	0.000647	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000188	0.000503	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000188	0.000503	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000172	0.00046	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00016	0.000428	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000151	0.000402	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000136	0.000364	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000103	0.000276	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	9.53e-05	0.000254	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	7.83e-05	0.000209	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.21e-05	0.000112	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.86e-05	0.000103	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.18e-05	8.49e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.18e-05	5.82e-05	CbGpPWpGaD
